Mayne Pharma Group Ltd
ASX:MYX
Gross Margin
Mayne Pharma Group Ltd
Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.
Gross Margin Across Competitors
| Country | AU |
| Market Cap | 578.5m AUD |
| Gross Margin |
68%
|
| Country | JP |
| Market Cap | 776 550.9T JPY |
| Gross Margin |
-3%
|
| Country | US |
| Market Cap | 733.3B USD |
| Gross Margin |
80%
|
| Country | DK |
| Market Cap | 3.9T DKK |
| Gross Margin |
85%
|
| Country | UK |
| Market Cap | 440.4B GBP |
| Gross Margin |
56%
|
| Country | US |
| Market Cap | 360.6B USD |
| Gross Margin |
70%
|
| Country | US |
| Market Cap | 329.8B USD |
| Gross Margin |
75%
|
| Country | UK |
| Market Cap | 191.2B GBP |
| Gross Margin |
82%
|
| Country | CH |
| Market Cap | 177.2B CHF |
| Gross Margin |
73%
|
| Country | CH |
| Market Cap | 177.1B CHF |
| Gross Margin |
74%
|
| Country | US |
| Market Cap | 159.1B USD |
| Gross Margin |
70%
|
Profitability Report
View the profitability report to see the full profitability analysis for Mayne Pharma Group Ltd.
See Also
Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.
Based on Mayne Pharma Group Ltd's most recent financial statements, the company has Gross Margin of 68.1%.
You don't have any saved screeners yet
